Cost –effectiveness of CYP2C19 LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndrome

Pharmacogenomics,Volume 21, Issue 1, Page 33-42, January 2020.

Source: Future Medicine: Pharmacogenomics - December 17, 2019 Category: Genetics & Stem Cells Authors: Yu Fu Xin-yi Zhang Si-bei Qin Xiao-yan Nie Lu-wen Shi Hong Shao Jian Liu Source Type: research